Femme et Homme
- | Pays :
- France
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to determine whether fractionated RIT with Epratuzumab and radiolabeled Epratuzumab are effective in the treatment of relapsing or refractory ALL.
Critère d'inclusion
- Acute Lymphoblastic Leukemia